Epidemiology of Resistance Determinants Identified in Meropenem-Nonsusceptible <i>Enterobacterales</i> Collected as Part of a Global Surveillance Study, 2018 to 2019-Reference-Cited by-同舟云学术

Epidemiology of Resistance Determinants Identified in Meropenem-Nonsusceptible Enterobacterales Collected as Part of a Global Surveillance Study, 2018 to 2019

Published:2023-05-17 Issue:5 Volume:67 Page:
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Estabrook Mark¹,Muyldermans Astrid²,Sahm Daniel¹,Pierard Denis²,Stone Gregory³,Utt Eric³^ORCID

Affiliation:

1. IHMA, Schaumburg, Illinois, USA

2. Department of Microbiology and Infection Control, Vrije Universiteit Brussel, Universitair Ziekenhuis Brussel, Brussels, Belgium

3. Pfizer Inc., Gorton, Connecticut, USA

Abstract

The objective of this study was to describe the frequency of resistance determinants in meropenem-nonsusceptible (MEM-NS) Enterobacterales isolates collected in 2018 and 2019 as a part of the ATLAS global surveillance program. Among a total of 39,368 Enterobacterales isolates collected in 2018 and 2019, 5.7% were MEM-NS (MIC ≥2 μg/mL).

Funder

Pfizer

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/aac.01406-22

Reference24 articles.

1. The global epidemiology of carbapenemase-producing Enterobacteriaceae

2. What’s new in multidrug-resistant pathogens in the ICU?

3. Carbapenemases: Partners in crime